People: Abcam PLC (ABCA.L)
Mr. Peter Vance Allen is Non-Executive Chairman of the Board of the Company. Peter has over 20 years’ experience as an executive director, non-executive director and chairman in a wide range of life science companies playing a significant role in their growth. He spent three years as Chairman of Proximagen Neurosciences plc (2009-2012), six years at ProStaken Group plc as Chairman (2007–2013) and interim CEO (2010–2011) and twelve years at Celltech Group plc (1992–2004) as CFO and Deputy CEO. Peter is currently Non-Executive Chairman of AIM listed Advanced Medical Solutions plc, Clinigen plc and Diurnal plc and privately-owned Oxford Nanopore Technologies Ltd. He is a Non-Executive Director of Istesso Ltd. A chartered accountant by background, Peter is an experienced chairman and board member and has substantial experience in M&A, international growth, fundraising and investor relations, as well as the commercialisation of intellectual property.
|Total Annual Compensation, GBP||9,000|
|Restricted Stock Award, GBP||--|
|Long-Term Incentive Plans, GBP||--|
|All Other, GBP||--|
|Fiscal Year Total, GBP||9,000|